April 4, 2024Announcement no. 6 Notice convening the Annual General Meeting in BioPorto A/S The Board of Directors hereby convenes the Annual General Meeting of BioPorto A/S to be held on: .
finanzen.at - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanzen.at Daily Mail and Mail on Sunday newspapers.
The Danish company has forecast overall revenue of approximately DKK 30 (US$4.9 million) for 2021 BioPorto said that, in the first quarter, it pushed hard on clinical programs for its NGAL Test for pediatric acute kidney injury and a coronavirus test
BioPorto A/S (CPH:BIOPOR) (FRA:2P4) has shared an interim report which showed that its first-quarter 2021 revenue grew by 33% driven by “strong sales of antibodies” and its flagship NGAL acute kidney-injury test.
The in-vitro diagnostic company based in Hellerup, Denmark, said that revenue from product sales of its proprietary NGAL Test remained at last year’s “high level” with a “solid performance” in the United States.